Theravance Biopharma(Delisted) TBPH
$0.00 +$0.00 (0.00%)
Market closed · Oct 24, 12:40 am ET
Open$0.00
Prev close$0.00
Day range$0.00 – $0.00
Volume0.00
Market cap$884.18M
P/E (TTM)16.4
Dividend yield–
TBPH Stock News
Headlines matching Theravance Biopharma(Delisted) or the TBPH ticker, most recent first.
- Theravance Biopharma(Delisted): Theravance Biopharma, Inc. - Cash Settlement/Acceleration of Expirations Option Symbol: TBPH
- Theravance Biopharma(Delisted): Theravance Biopharma, Inc.- Broker-To-Broker Settlement/Exercise Considerations Option Symbol: TBPH
- Theravance Biopharma: Theravance Biopharma, Inc. - Anticipated Cash Settlement Option Symbol: TBPH
- Analysts' Opinions Are Mixed on These Healthcare Stocks: Rocket Pharmaceuticals (RCKT), Fractyl Health, Inc. (GUTS) and Theravance Biopharma (TBPH)
- H.C. Wainwright Maintains Theravance Biopharma(TBPH.US) With Hold Rating, Maintains Target Price $17
- H.C. Wainwright Downgrades Theravance Biopharma(TBPH.US) to Hold Rating, Raises Target Price to $17 Mixed
- Theravance Biopharma(TBPH.US) 10% Shareholder Sells US$5.79 Million in Common Stock
- BTIG Downgrades Theravance Biopharma(TBPH.US) to Hold Rating Negative
- Analysts Offer Insights on Healthcare Companies: Evommune, Inc. (EVMN) and Theravance Biopharma (TBPH)
- BTIG Maintains Theravance Biopharma(TBPH.US) With Buy Rating, Maintains Target Price $21
- JonesTrading Maintains Theravance Biopharma(TBPH.US) With Buy Rating, Raises Target Price to $19 Positive
- B. Riley Securities Maintains Theravance Biopharma(TBPH.US) With Hold Rating, Raises Target Price to $17 Positive
- Oppenheimer Downgrades Theravance Biopharma(TBPH.US) to Hold Rating, Cuts Target Price to $13.67 Negative
- JonesTrading Maintains Theravance Biopharma(TBPH.US) With Buy Rating, Cuts Target Price to $17 Negative
- H.C. Wainwright Maintains Theravance Biopharma(TBPH.US) With Buy Rating, Cuts Target Price to $15 Negative
No comments yet — be the first to weigh in on TBPH.
Sign in to join the discussion.